CHINESE JOURNAL OF DRUG EVALUATION >

2026 , Vol. 43 >Issue 3: 165 - 165-169

DOI: https://doi.org/10.2095-3593.2026.050017

Analysis and Reflection on Typical Cases of Illegal and Irregular Online Pharmaceutical Sales

  • LiuShan
Expand
  • Inspection Center of Guizhou Provincial Drug Administration，Guizhou Guiyang 550081， China

Received date: 2025-11-11

  Accepted date: 2026-05-19

  Online published: 2026-08-12

Fold

Abstract

Objective： To clarify the specific manifestations of illegal and irregular behaviors in online pharmaceutical sales in China， thereby providing references for drug regulatory authorities to conduct supervision and law enforcement in this field. Methods： Seven batches of typical cases of illegal and irregular online pharmaceutical sales published on the official website of the National Medical Products Administration from 2023 to 2024 were sorted out. The clue sources， types of illegal entities， case causes， administration panalties in these typical cases were analyzed. Results： Through case analysis， various manifestations and related characteristics of illegal and irregular behaviors in the field of online pharmaceutical sales were identified. Conclusion： Targeted thoughts and suggestions are put forward from multiple perspectives including laws and regulations， supervision mechanisms， platform responsibilities， and enterprise self-discipline， aiming to promote the standardized and healthy development of the online pharmaceutical sales and ensure the public′s medication safety.

Key words： ; font-size:medium; ">Online pharmaceutical sales； Typical cases； Supervision； Medication safety

Cite this article

LiuShan . Analysis and Reflection on Typical Cases of Illegal and Irregular Online Pharmaceutical Sales[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2026 , 43(3) : 165 -165-169 . DOI: 10.2095-3593.2026.050017

References

[1] 米内网. 网上药店销售规模首超1000亿，药品销售额暴增40%[EB/OL]. (2020-0-26) [2025-11-02]. https： //3g. menet. com. cn/Article/Detial?aId=140035.
     [2] 米内网. 一文读懂|2024年零售终端药品销售规模达5740亿元，增速持续放缓[EB/OL]. (2025-02-17) [2025-11-02]. https： //3g. menet. com. cn/Article/Detial?aid=148607.
     [3] 米内网. 网上药店大涨超20%！40个畅销品牌出炉，国药集团、同仁堂……上榜 [EB/OL]. (2025-10-09) [2025-11-02]. https： //xueqiu. com/5923081507/355731943.
     [4] 施能进，石林勇，刘会佳. 药品网络销售质量风险防控及检查方法[J]. 黑龙江医药，2024，6（24）： 1316-1320.
     [5] 国家药品监督管理局．国家药监局公布5起药品网络销售违法违规典型案例（第四批）[EB/OL]. (2024-01-15) [2025-11-02]. https： //www. nmpa. gov. cn/yaowen/ypjgyw/ypyw/2024 0115172350140. html.
     [6] 国家药品监督管理局. 国家药监局公布5起药品网络销售违法违规典型案例（第五批）[EB/OL]. (2024-04-23) [2025-11-02]. https： //www. nmpa. gov. cn/yaowen/ypjgyw/ypyw/ 20240423085604182. html.
     [7] 国家药品监督管理局. 国家药监局公布4起药品网络销售违法违规典型案例（第六批）[EB/OL]. (2024-09-18) [2025-11-02]. https： //www. nmpa. gov. cn/ yaowen/ypjgyw/ypyw/20240918155149184. html.
     [8] 国家药品监督管理局. 国家药监局公布4起药品网络销售违法违规典型案例（第七批）[EB/OL]. (2024-12-23) [2025-11-02]. https： //www. nmpa. gov. cn/yaowen/ ypjgyw/ypyw/20241223155702158. html.
     [9] 黄炳生，吴生齐，张征. 我国药品网络销售现存风险及监管对策建议[J]. 中国药业，2022，31(10)：18-21.
     [10] 徐光辉，黄守勤，江灵芝. 药品网络销售监管问题与对策研究[J]. 卫生经济研究，2025，42（6）：32-39.
     [11] 吴少杰. 药品网络监管 如何念好紧箍咒[N]. 健康报，2024-01-30（002）.
     [12] 徐维兴，药品网络销售风险及建议探析[J]. 中国药事，2025，39（5）：492-498.
Options
Outlines

/

〈 〉

[an error occurred while processing this directive]